Ford Motor Company (F): The Flavor of the Season?

Ford Motor Company (NYSE:F) is back on the radar of analysts and investors. During the financial crisis of 2007-08, Ford Motor Company (NYSE:F) was beaten down almost to the stature of a penny stock, but since its lowest price in the second half of 2008 till now, the stock has surged by more than 1,000%. Now that most of its problems have been taken care of, investors are looking at Ford Motor Company (NYSE:F) from a different perspective. Bryan Piskorowski from Wells Fargo Advisors and Michael Binger of Gradient Investments, have recently discussed  on CNBC why every investor should consider owning shares of Ford Motor Company (NYSE:F) in their portfolio.

“I think Ford Motor Company (NYSE:F) is a perfect type of stock to own at this point in the market cycle, it’s a cheap stock, they just had a good quarter. I think the F 150 is going to be a killer product for them. International profitability which has been gone forever is finally here at this point of time and finally it has a great dividend that will pay us. So, it’s cheap, I think it will start growing again; they have got a great product […],” Binger said.


Binger also mentioned that the vehicle fleet in the U.S. has grown old and it is going to be replaced, which makes it another reason for owning Ford Motor Company (NYSE:F)’s stock.

According to Piskorowski, similar to Ford Motor Company (NYSE:F), the overall industrial sector looks good for investments. He feels that 2014 has been a year of broadening global growth and industrial is one area which investors should look to play. Piskorowski believes that in this stage of the market cycle, investors are going to see a lot of rotation. Whereas the defensive stocks have performed very well up until now, the cyclical stocks will take the lead from here on. Piskorowski mentioned that though he is still bullish on the market, he will wait for a correction to buy more stocks.

Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!